Successful Crackdown on Illegal Use of Methylphenidate

Regulations by 2FIRSTS.ai
Nov.20.2023
Successful Crackdown on Illegal Use of Methylphenidate
Seven suspects were arrested in Ganzhou, Jiangxi for illegal use of illicit substance meprobamate in e-cigarette manufacturing.

According to the news on November 20th from Guizhou Internet Radio and Television Station, the Xinfeng police in Ganzhou, Jiangxi recently successfully cracked a case involving the use of methyl ethyl ketone to produce "Shangtou e-cigarettes". In total, seven suspects involved in illegal activities were arrested.

Successful Crackdown on Illegal Use of Methylphenidate

 

According to data from the police, the urine test results of arrested suspects have all shown positive for eutylone. On the other hand, cases related to eutylone have also been successively cracked in Xishui, Hubei and Yuncheng, Guangdong, once again highlighting the dangers of eutylone in the illegal market.

 

Dependence on Etomidate", known as a type of prescription anesthetic, can only be legally used by medical institutions that have obtained a "Pharmaceutical Business License." Similarly, only pharmaceutical wholesale and retail enterprises with a "Pharmaceutical Business License" can sell raw materials and preparations of "Etomidate.

 

In September of this year, the National Medical Products Administration, Ministry of Public Security, and National Health Commission issued a public announcement regarding the adjustment of the catalogue of anesthetic and psychotropic drugs. It states that methylphenidate will be included in the second category of the psychotropic drug catalogue, excluding drugs containing methylphenidate that have been approved for sale within China. This adjustment will take effect from October 1, 2023.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

NYC Reaches Settlement with E-Cigarette Distributors in Flavored Vape Crackdown
NYC Reaches Settlement with E-Cigarette Distributors in Flavored Vape Crackdown
New York City has reached settlement agreements with two e-cigarette wholesalers accused of selling flavored vapes illegally. The companies agreed to stop all flavored vape transactions in the city and face $1,000 fines for future violations. Litigation against other defendants in the broader case continues.
Nov.25 by 2FIRSTS.ai
ceshi
ceshi
Nov.04
South Korea Plans Unified Regulation for Synthetic and Look-Alike Nicotine Products
South Korea Plans Unified Regulation for Synthetic and Look-Alike Nicotine Products
South Korea Parliament discusses including "nicotine" in Tobacco Business Act; synthetic nicotine testing method established, awaiting legislation approval.
Oct.22 by 2FIRSTS.ai
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
President Donald Trump signed the Continuing Appropriations Act, 2026 (H.R.5371) on November 12, Section 772 of Part B—the Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act (S.2256)—requires the FDA to allocate no less than $200 million in tobacco user fees to enforce regulations against illegal e-cigarettes, vapes, and other ENDS products. At least $2 million of this funding supports a federal multi-agency task force targeting products originating from the China.
Nov.14 by 2FIRSTS.ai
2025 China Shenzhen Top 500 Enterprises List: 13 E-cigarette Companies Include
2025 China Shenzhen Top 500 Enterprises List: 13 E-cigarette Companies Include
Shenzhen e-commerce companies dominate 2025 Top 500 list, including 13 e-cigarette businesses. Shenzhen FirstUnion Tech climbs 57 spots.
Oct.30 by 2FIRSTS.ai
U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned
U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned
Turning Point Brands (NYSE: TPB) released its financial results for the third quarter of 2025, reporting strong revenue and profit growth driven by surging Modern Oral (nicotine pouch) sales. The company announced plans to establish its first U.S.-based white pouch production line in 2026, marking a key step toward manufacturing localization.
Nov.06 by 2FIRSTS.ai